Replies to post #90135 on Elite Pharmaceuticals Inc (ELTP)

[slapy52]

Of the drugs that were mentioned in the PR this morning that we are waiting on CBE's for... what is the market for the drugs and how many competitors?

[pgp419]

Patent issued in 2 weeks !!!

[rdragon]

March will be very interesting.
It sounded like to me we will also have a partner in March, after BE trial are complete.
My guess is the partner will be pretty well lined up, waiting to see results to sign.
We shall see

Great CC

Mr Nasrat does not mess around!

[richme]

Have not seen this posted; if it has sorry. Quote in part:

http://money.msn.com/business-news/article.aspx?feed=PZ&date=20140218&id=17357102

NORTHVALE, N.J., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today successful results from a pilot bioequivalence study initiated in December 2013 for ELI-201, a twice-daily opioid abuse deterrent oxycodone product with abuse deterrent technology. Three different twice daily formulations developed by Elite were tested in the study. The study results demonstrate that all formulations in the study were bioequivalent to the reference drug based on pharmacokinetic measures including peak plasma concentration (Cmax) and area under the curve (AUC) for oxycodone blood plasma levels. The study was a single dose, open label, randomized, four period, four treatment, cross over study in 16 healthy volunteers under fasted conditions.